World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 106 6531 6140 210 196 412 42013

Piero Ruggenenti publications per year

The chart shows the history of publications by Piero Ruggenenti between 1987 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Piero Ruggenenti published across 39 years, from 1987 to 2025, averaging 10.8 papers a year. Output peaked at 24 publications in 2021. 8 of the 420 publications appeared in the last two years.

No. of publications
5 10 15 20
Bar chart. Horizontal axis: year, 1987 to 2025. Vertical axis: number of publications, 0 to 24. Peak 24 publications in 2021. 1987: 1 publication 1988: 0 publications 1989: 1 publication 1990: 3 publications 1991: 7 publications 1992: 5 publications 1993: 8 publications 1994: 5 publications 1995: 4 publications 1996: 6 publications 1997: 9 publications 1998: 13 publications 1999: 11 publications 2000: 11 publications 2001: 12 publications 2002: 11 publications 2003: 18 publications 2004: 18 publications 2005: 14 publications 2006: 15 publications 2007: 13 publications 2008: 12 publications 2009: 18 publications 2010: 20 publications 2011: 20 publications 2012: 14 publications 2013: 15 publications 2014: 11 publications 2015: 12 publications 2016: 7 publications 2017: 12 publications 2018: 10 publications 2019: 14 publications 2020: 5 publications 2021: 24 publications 2022: 13 publications 2023: 20 publications 2024: 3 publications 2025: 5 publications
1987 2025

420 publications in total across all disciplines

View publications per year as a table
Piero Ruggenenti: publications per year, 1987 to 2025
Year Publications
1987 1
1988 0
1989 1
1990 3
1991 7
1992 5
1993 8
1994 5
1995 4
1996 6
1997 9
1998 13
1999 11
2000 11
2001 12
2002 11
2003 18
2004 18
2005 14
2006 15
2007 13
2008 12
2009 18
2010 20
2011 20
2012 14
2013 15
2014 11
2015 12
2016 7
2017 12
2018 10
2019 14
2020 5
2021 24
2022 13
2023 20
2024 3
2025 5
Total 420
Download as CSV

Piero Ruggenenti publications per year - data summary

  • Piero Ruggenenti, a Medicine scholar from Mario Negri Institute for Pharmacological Research, has 420 publications recorded across 39 years, from 1987 to 2025.
  • The oldest publication on record dates to 1987 and the most recent to 2025.
  • The most productive year is 2021, with 24 publications.
  • The least productive years with any output are 1987 and 1989, with 1 publication each.
  • 1 of the 39 years in the span carries no publications at all (1988).
  • The rate of publication averages 10.8 papers per year over the whole span, or 11.1 per year counting only the 38 years with at least one publication.
  • The last 5 years on the chart (2021-2025) hold 65 publications, 15% of the career total.
  • Split into equal eras - 1987-1999: 73 publications (5.6 per year); 2000-2012: 196 publications (15.1 per year); 2013-2025: 151 publications (11.6 per year).
  • Comparing the opening and closing eras, the overall trend of publication is rising.

Piero Ruggenenti publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Piero Ruggenenti sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 401–420 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 412 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918 412
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Piero Ruggenenti publication distribution in Medicine in 2026 - data summary

  • The chart plots the publication count of all 20,134 Medicine scientists ranked by Research.com in 2026, grouped into 86 ranges running from 101–120 to 1,796+ publications.
  • Piero Ruggenenti, a Medicine scholar from Mario Negri Institute for Pharmacological Research, records 412 publications - the 41st percentile of the discipline.
  • 41% of ranked Medicine scientists score the same or lower than Piero Ruggenenti, and about 59% score higher.
  • The median of the discipline falls in the 441–460 publications range, and Piero Ruggenenti ranks below the median.
  • The most crowded range is 341–360 publications, holding 922 scientists (5% of the field).
  • 64% of the field sits in the lowest quarter of the value range (up to 521–540 publications), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 1,796 publications or more, 100 scientists in all (<1% of the field).

Piero Ruggenenti D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Piero Ruggenenti sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 106–107 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 106 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541 106
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Piero Ruggenenti D-index placement in Medicine in 2026 - data summary

  • The chart plots the discipline H-index (D-index) of all 20,134 Medicine scientists ranked by Research.com in 2026, grouped into 75 ranges running from 70–71 to 217+ D-Index.
  • Piero Ruggenenti, a Medicine scholar from Mario Negri Institute for Pharmacological Research, records 106 D-Index - the 69th percentile of the discipline.
  • 69% of ranked Medicine scientists score the same or lower than Piero Ruggenenti, and about 31% score higher.
  • The median of the discipline falls in the 94–95 D-Index range, and Piero Ruggenenti ranks above the median.
  • The most crowded range is 82–83 D-Index, holding 1,027 scientists (5% of the field).
  • 70% of the field sits in the lowest quarter of the value range (up to 106–107 D-Index), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 217 D-Index or more, 98 scientists in all (<1% of the field).

Overview

Piero Ruggenenti is affiliated with the Mario Negri Institute for Pharmacological Research in Italy. Their research primarily focuses on the field of Medicine, with particular emphasis on Nephrology, Infectious Diseases, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, and Pulmonary and Respiratory Medicine.

Their recent publications include:

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis, 2021, The Lancet
  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis, 2021, The Lancet
  • Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial, 2020, The Lancet Diabetes & Endocrinology
  • Glomerular hyperfiltration, 2022, Nature Reviews Nephrology
  • A meta-analysis of GFR slope as a surrogate endpoint for kidney failure, 2023, Nature Medicine

The frequent co-authors who have collaborated extensively with Ruggenenti include Giuseppe Remuzzi, Annalisa Perna, Nadia Rubis, Tobia Peracchi, and Norberto Perico.

The main research topics covered in Ruggenenti's work encompass:

  • Renal Diseases and Glomerulopathies
  • COVID-19 Clinical Research Studies
  • Chronic Kidney Disease and Diabetes
  • Renal Transplantation Outcomes and Treatments
  • Blood Pressure and Hypertension Studies
  • Diabetes Treatment and Management
  • Long-Term Effects of COVID-19

Publications by Ruggenenti appear frequently in venues such as The Nephron journals, Journal of the American Society of Nephrology, The Lancet, Clinical Kidney Journal, and EClinicalMedicine.

Best Publications

  • Preventing microalbuminuria in type 2 diabetes.

    Piero Ruggenenti;Anna Fassi;Anelja Parvanova Ilieva;Simona Bruno

  • Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

    Piero Ruggenenti;Annalisa Perna;Giulia Gherardi;Giovanni Garini

  • Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

    Brad C. Astor;Kunihiro Matsushita;Ron T. Gansevoort;Marije Van Der Velde

  • Understanding the nature of renal disease progression

    Giuseppe Remuzzi;Piero Ruggenenti;Ariela Benigni

  • Nephropathy in Patients with Type 2 Diabetes

    Giuseppe Remuzzi;Arrigo Schieppati;Piero Ruggenenti

  • Progression, remission, regression of chronic renal diseases.

    Piero Ruggenenti;Arrigo Schieppati;Giuseppe Remuzzi

  • Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial

    Piero Ruggenenti;Annalisa Perna;Giulia Gherardi;Flavio Gaspari

  • Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza

  • Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial.

    Piero Ruggenenti;Annalisa Perna;Giacomina Loriga;Maria Ganeva

  • Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura

    Piero Ruggenenti;Marina Noris;Giuseppe Remuzzi

  • The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease

    Giuseppe Remuzzi;Norberto Perico;Manuel Macia;Piero Ruggenenti

  • Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies

    Piero Ruggenenti;Annalisa Perna;Lidia Mosconi;Roberto Pisoni

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

    Kazem Rahimi;Zeinab Bidel;Milad Nazarzadeh;Emma Copland

  • Long-Term Outcome of Renal Transplantation from Older Donors

    Giuseppe Remuzzi;Paolo Cravedi;Annalisa Perna;Borislav D. Dimitrov

  • Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.

    Tazeen H Jafar;Paul C Stark;Christopher H Schmid;Marcia Landa

  • Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate.

    Flavio Gaspari;Norberto Perico;Piero Ruggenenti;Lidia Mosconi

  • Early Experience with Dual Kidney Transplantation in Adults using Expanded Donor Criteria

    Giuseppe Remuzzi;Josep Grinyò;Piero Ruggenenti;Marco Beatini

  • Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease

    Aiko P J de Vries;Piero Ruggenenti;Xiong Z Ruan;Xiong Z Ruan;Manuel Praga

  • Rituximab for idiopathic membranous nephropathy

    Giuseppe Remuzzi;Carlos Chiurchiu;Mauro Abbate;Verusca Brusegan

  • ATYPICAL HEMOLYTIC UREMIC SYNDROME AND C3 GLOMERULOPATHY: CONCLUSIONS FROM A «KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES» (KDIGO) CONTROVERSIES CONFERENCE

    Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza

Frequent Co-Authors

Giuseppe Remuzzi
Giuseppe Remuzzi Mario Negri Institute for Pharmacological Research
Norberto Perico
Norberto Perico Mario Negri Institute for Pharmacological Research
Andrea Remuzzi
Andrea Remuzzi University of Bergamo
Marina Noris
Marina Noris Mario Negri Institute for Pharmacological Research
Peter Rossing
Peter Rossing University of Copenhagen
Dick de Zeeuw
Dick de Zeeuw University of Groningen
Ariela Benigni
Ariela Benigni Mario Negri Institute for Pharmacological Research
Barry M. Brenner
Barry M. Brenner Brigham and Women's Hospital
Gerjan Navis
Gerjan Navis University Medical Center Groningen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees can be a smart way to begin or advance your medical career in the USA. For those looking for a quicker route to start working in the field, there are 6 month lpn program options that prepare you for entry-level nursing roles in less time.

If you’re seeking advanced practice or specialization, consider the fastest pmhnp program to become a psychiatric mental health nurse practitioner. These accelerated online programs allow you to continue working while developing new skills and expanding your career opportunities.

Another growing avenue is healthcare administration. Earning your MHA online gives you flexible options for learning, with the best online mha programs offering respected curriculums for future leaders. Cost is an important consideration; the cheapest online mha programs can help you manage expenses while pursuing a valuable credential.

These diverse online degrees are tailored for different career goals—whether direct patient care, mental health, or healthcare management—making them excellent pathways alongside or as alternatives to studying traditional Medicine in the USA.

Best Scientists Citing Piero Ruggenenti

Trending Scientists

Recently Published Articles